Viruses, Variants, and Vaccines: How COVID-19 Has Changed the Way We Look at Skin

    October 2022 in “ Current Dermatology Reports ”
    Rhea Singh, Esther E. Freeman
    Image of study
    TLDR COVID-19 and vaccines cause various skin reactions and highlight the need for dermatologists in managing these issues and addressing vaccine distribution disparities.
    The review discusses the various skin reactions following SARS-CoV-2 infection and COVID-19 vaccination, with over 30 different rashes identified post-infection, including morbilliform or maculopapular rashes, chilblains, and urticaria. Hair loss in the forms of alopecia areata and telogen effluvium has also been recorded. Post-vaccination cutaneous reactions occurred in 9% of larger cohort studies, more frequently with mRNA-based COVID-19 vaccines. These reactions included delayed large local reactions, local injection site reactions, urticarial eruptions, and morbilliform eruptions. Other reactions include herpes zoster reactivation, pernio/chilblains flare, erythema multiforme, bullous disease, hair loss, and psoriasis flare. The document emphasizes the role of dermatologists in evaluating these manifestations and promoting COVID-19 vaccination. It also highlights the disparities in vaccine distribution, with 19.4% of individuals in low-income countries having received one dose of the vaccine compared to 78.4% in high-income countries as of June 1, 2022.
    Discuss this study in the Community →

    Research cited in this study

    7 / 7 results

    Related Community Posts Join

    6 / 1000+ results
      Diffuse hair loss and scalp biopsies

      community Diffuse hair loss and scalp biopsies

      in Research  692 upvotes 4 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community HLT Megathread on HMI-115 (key takeaways in comments)

      in Research/Science  39 upvotes 1 year ago
      HMI-115, a newly discovered hair loss treatment that could potentially be effective for those with diffuse thinning and telogen effluvium. It is based on prolactin receptor antagonist signaling and has already undergone Phase I trials in women, with potential commercialization by 2027.

      community I am a dermatologist with a clinical interest in alopecia. AMA

      in Will treatment work for me? 2 years ago
      In this conversation, 4990 discussed various treatments for hair loss, including oral minoxidil, PRP, transplan, Jak inhibitors, Dutasteride, Finasteride, Olumiant, Ketoconazole, RU58841, microneedling, baricitinib, and CCCA. They recommended scalp biopsies in unclear cases of DUPA, twice weekly to twice daily shampooing for topical minoxidil users, and two sessions spaced one month apart with follow up at month three to determine the effectiveness of PRP treatment.

    Similar Research

    6 / 1000+ results